BEHAVIORAL PHARMACOLOGY OF CENTRAL-NERVOUS-SYSTEM STIMULANTS

[1] Dews PB, 1977, ADV BEHAV PHARMACOL, V1, P167

[2] GLICK SD, 1976, BEHAVIORAL PHARM

[3] HARVEY JA, 1971, BEHAVIORAL ANAL DRUG

[4] HARVEY JA, 1987, IN PRESS PSYCHOPHARM

[5] IVERSEN SD, 1975, BEHAVIORAL PHARM

[6] INCREASED SENSITIVITY TO D-AMPHETAMINE AND L-AMPHETAMINE ACTION AFTER MIDBRAIN RAPHE LESIONS AS MEASURED BY LOCOMOTOR-ACTIVITY [J]. NEUROPHARMACOLOGY, 1979, 18 (03) : 243 - 249

[7] MACKINTOSH JH, 1977, HDB PSYCHOPHARMACOLO, P3

[8] MCGAUGH JL, 1980, NEURAL MECHANISMS GO, P75

[9] MCKEARNEY JW, 1972, SCHEDULE EFFECTS DRU, P3

[10] MCKIM WA, 1986, DRUGS BEHAVIOR

[1] Dews PB, 1977, ADV BEHAV PHARMACOL, V1, P167

[2] GLICK SD, 1976, BEHAVIORAL PHARM

[3] HARVEY JA, 1971, BEHAVIORAL ANAL DRUG

[4] HARVEY JA, 1987, IN PRESS PSYCHOPHARM

[5] IVERSEN SD, 1975, BEHAVIORAL PHARM

[6] INCREASED SENSITIVITY TO D-AMPHETAMINE AND L-AMPHETAMINE ACTION AFTER MIDBRAIN RAPHE LESIONS AS MEASURED BY LOCOMOTOR-ACTIVITY [J]. NEUROPHARMACOLOGY, 1979, 18 (03) : 243 - 249

[7] MACKINTOSH JH, 1977, HDB PSYCHOPHARMACOLO, P3

[8] MCGAUGH JL, 1980, NEURAL MECHANISMS GO, P75

[9] MCKEARNEY JW, 1972, SCHEDULE EFFECTS DRU, P3

[10] MCKIM WA, 1986, DRUGS BEHAVIOR